The Deal
Sunday, November 8, 
3:08 pm

Could Bayer be taken over by Pfizer?

  Share     E-Mail    Discussion    Print Story
pfizer.jpgTakeover rumors of Bayer AG by New York-based Pfizer Inc. boosted shares of the German drugs and chemicals group Tuesday morning.

Continue reading below

Also on Dealscape

A Reuters report said a Pfizer purchase of Bayer could be complicated since the company would have to break up Bayer's chemical-drugs combo. Nonetheless, Pfizer is a highly acquisitive company with a penchant for transformative megadeals like its acquisitions of Pharmacia and Warner-Lambert. However, it hasn't made any major purchases in a few years, and its blockbuster cholesterol fighter Lipitor goes off patent in 2011 -- perhaps these developments are feeding the speculation it will bid on Bayer. - Maria Woehr

See story from Reuters
See related story about Pfizer's most recent purchase from TheDeal.com



Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.